Anika Therapeutics (ANIK) vs Mobia Medical (MOBI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Mobia Medical is the larger company by market cap ($287.3 million vs $262.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIK | MOBI |
|---|---|---|
| Share price | $19.58 | $8.63 |
| Market cap | $262.04M | $287.30M |
| 1-day change | +1.82% | +0.82% |
| YTD return | +100.10% | — |
| 1-year return | +108.12% | — |
| 5-year return | -53.84% | — |
| Forward P/E | 20.61 | — |
| EPS (TTM) | $-0.23 | $-2.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.88 | $15.29 |
| 52-week low | $8.67 | $8.29 |
| Distance from 52-week high | -14.42% | -43.56% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +17.47% | +105.68% |
| Average volume | 99.71K | 180.32K |
| Shares outstanding | 13.38M | 33.29M |
| Employees | 235 | 167 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
About Mobia Medical
MOBI stock →Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.
Health Care · Medical/Dental Instruments · 167 employees
ANIK vs MOBI FAQ
Which is bigger, Anika Therapeutics or Mobia Medical?
Mobia Medical (MOBI) is larger, with a market capitalization of $287.30M compared with $262.04M for Anika Therapeutics (ANIK).
Are Anika Therapeutics and Mobia Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.